| CEO: | Sean M. Smith |
| CFO: | Alexander John Abrey |
| Non-Executive Chairman: | Lykele van der Broek |
| Non-Executive Dir: | Derek McAllan, Robin James Scott Cridland |
| Address: | 67C Innovation Drive, Milton Park, Abingdon, Oxfordshire, England, United Kingdom, OX14 4RQ |
| Website: | http://www.edenresearch.com/ |
| Sector: | Pharma and Biotech(LSE) |
| Index: | FTSE AIM All-Share |
| ISIN: | GB0001646941 |
| Currency | UK Pounds |
| Share Price | 4.83p |
| Change Today | 0.033p |
| % Change | 0.69 % |
| 52 Week High | 4.84 |
| 52 Week Low | 2.10 |
| Volume | 20,958 |
| Shares Issued | 533.35m |
| Market Cap | £25.78m |
| Beta | 0.51 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 08:13 | 20,163 @ 4.71p |
| 08:05 | 795 @ 4.84p |
| CFO | Alexander John Abrey |
| CEO | Sean M. Smith |
You are here: research